Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

VITAMIN D DEFICIENCY IN PATIENTS WITH OSTEOARTHRITIS UNDERGOING TOTAL HIP ARTHROPLASTY A CAUSE FOR CONCERN?



Abstract

Introduction: The presence of low levels of vitamin D in osteoarthritic patients has been reported as a substantial problem. We are not aware of any previous studies that have assessed the function of osteoarthritic patients undergoing joint replacement who are vitamin D deficient. This may be an important factor infiuencing preoperative function and postoperative outcome. The aim of this study was to investigate whether low vitamin D levels are associated with functional deterioration in patients with osteoarthritis of the hip undergoing total hip arthroplasty.

Methods: We measured plasma 25-hydroxyvitamin D3 (25(OH)D3) levels in 62 consecutive Caucasian patients undergoing total hip arthroplasty for osteoarthritis. The patients were divided into two groups based on whether they were vitamin D sufficient or deficient. The groups were matched for age, gender and ASA grade.

Results: The prevalence of vitamin D deficiency in our cohort of patients was comparable to recent population-based studies performed in the UK. Patients with vitamin D deficiency had lower preoperative Harris hip scores (Mann-Whitney test, p = 0.018) and were significantly less likely to attain an excellent outcome from total hip arthroplasty (Chi-square test, p = 0.038). Vitamin D levels were found to positively correlate with both preoperative and postoperative Harris hip scores.

Discussion: Our results warrant further study of vitamin D deficiency in patients undergoing joint replacement as it is a risk factor for suboptimal outcome which is relatively simple and cheap to correct.

Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Tel: +41 44 448 44 00; Email: office@efort.org

Author: Danyal Nawabi, United Kingdom

E-mail: danyalnawabi@gmail.com